Stanford University
Showing 1-50 of 342 Results
-
Simone D'Amico
Associate Professor of Aeronautics and Astronautics and, by courtesy, of Geophysics
BioSimone D’Amico is Associate Professor of Aeronautics and Astronautics (AA), W.M. Keck Faculty Scholar in the School of Engineering, and Professor of Geophysics (by Courtesy). He is the Founding Director of the Space Rendezvous Laboratory and Director of the AA Undergraduate Program. He received the B.S. and M.S. degrees from Politecnico di Milano (2003) and the Ph.D. degree from Delft University of Technology (2010). Before Stanford, Dr. D’Amico was research scientist and team leader at the German Aerospace Center (DLR) for 11 years. There he gave key contributions to formation-flying and proximity operations missions such as GRACE (NASA/DLR), PRISMA (OHB/DLR/CNES/DTU), TanDEM-X (DLR), BIROS (DLR) and PROBA-3 (ESA). His research aims at enabling future miniature distributed space systems for unprecedented remote sensing, space and planetary science, exploration and spaceflight sustainability. To this end he performs fundamental and applied research at the intersection of advanced astrodynamics, spacecraft Guidance, Navigation and Control (GNC), autonomy, decision making and space system engineering. Dr. D’Amico is institutional PI of three upcoming autonomous satellite swarm missions funded by NASA and NSF, namely STARLING, VISORS, and SWARM-EX. He is Fellow of AAS, Associate Fellow of AIAA, Associate Editor of AIAA JGCD, Advisor of NASA and several space startups. He was the recipient of several awards, including Best Paper Awards at IAF (2022), IEEE (2021), AIAA (2021), AAS (2019) conferences, the Leonardo 500 Award by the Leonardo da Vinci Society/ISSNAF (2019), FAI/NAA’s Group Diploma of Honor (2018), DLR’s Sabbatical/Forschungssemester (2012) and Wissenschaft Preis (2006), and NASA’s Group Achievement Award for the GRACE mission (2004).
-
Genevieve D'Souza
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
BioGenevieve D’souza MD, FASA is a Clinical Associate Professor in the Pediatric Anesthesia division of the Department of Anesthesiology, Perioperative and Pain Medicine at Stanford University. She is a Board-certified Pediatric Anesthesiologist , Fellowship trained Pediatric Pain Doctor, and trained in Medical Acupuncture.
She is a practicing Chronic Pediatric Pain Doctor at Stanford Medicine Children's Health and is also part of the Acute Pain Service. She is the Interim Medical Director of the Pediatric Pain Division. She is also the Director of the Pediatric Anesthesia Resource Center at Lucile Packard Children’s Hospital.
She is also the Senior Editor for the Visual Pearl Series For the Society of Pediatric Pain Medicine and on the Board of Directors for Society of Pediatric Pain Medicine. -
Peter D'Souza
Clinical Associate Professor, Emergency Medicine
BioDr. D'Souza's clinical practice is in Emergency Medicine at Stanford Hospital. He has a strong interest in Emergency Medical Services and pre-hospital care. He currently serves as medical advisor for the Palo Alto Fire Department, Mountain View Fire Department, and Santa Clara Fire Department. He serves as the Department Liaison to the Trauma Service. He previously served as Medical Director for Stanford Life Flight and course director for the Stanford EMT Training Program. His research interests include treatment of neurological emergencies and variability in trauma care.
-
Saurabh Dahiya, MD, FACP
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
BioDr. Dahiya is a cancer specialist with board certification in internal medicine, hematology, and medical oncology. He is an Associate Professor at Stanford University School of Medicine and Clinical Director of Cancer Cell Therapy in the Stanford BMT and Cell Therapy division.
Dr. Dahiya strives to support each patient with a personalized and compassionate care plan that optimizes healing and quality of life.
Prior to joining Stanford, Dr. Dahiya was an associate professor of medicine at the Greenebaum Comprehensive Cancer Center at the University of Maryland School of Medicine, where he developed the Cellular Immunotherapy Program and served as the Director of Cellular Immunotherapy in leukemia and lymphoma.
Dr. Dahiya’s research focuses on cellular immunotherapy for hematologic malignancies. He has led and participated in several investigator-initiated studies and sponsored clinical trials with cell therapies (CAR-T, CAR-NK, TCR-T) for hematologic malignancies. His research group is also involved in various translational research activities for the standard of care and research CAR-T therapy. Dr. Dahiya’s group was the first group to show the role of fibrinogen in Neurotoxicity associated with CAR-T therapy. They showed vascular injury as manifested by high fibrinogen levels is associated with higher Neurotoxicity in patients who receive CAR-T therapy. More recently his group led a novel study of assessing the immune response to COVID-19 disease. They evaluated the immune response in critically ill and non-critically ill patients hospitalized with COVID-19 disease and showed a differential immune response between the groups. Dr. Dahiya’s group also showed and established poor immunogenicity of COVID-19 vaccines in CART recipients. As such, passive immunity and other strategies to address the issues of immunogenicity are being explored.
He has published more than 50 articles in peer-reviewed journals including the New England Journal of Medicine, Journal of Clinical Oncology, Blood, Blood Advances, Lancet, Leukemia Research, Neuro-Oncology, and many more. He reviews article submissions for the journals Critical Reviews in Oncology and Hematology, Thoracic Cancer, and Blood. He serves as the hematology lead editor for the journal Critical Reviews in Oncology and Hematology.
He has presented his research findings at conferences such as the annual meetings of the American Society of Hematology, American Society of Clinical Oncology, and American Society for Transplantation and Cell Therapy.
Dr. Dahiya is a member of the American Society of Hematology and the American Society of Transplantation and Cell Therapy. -
Gary Dahl
Professor of Pediatrics (Hematology/Oncology), Emeritus
Current Research and Scholarly InterestsHematology/Oncology, Phase I drug studies for childhood cancer, overcoming multidrug resistance in leukemia and solid tumors, biology and treatment of acute nonlymphocytic leukemia, early detection of central nervous system leukemia by measuring growth, factor binding proteins.
-
Jeremy Dahl
Associate Professor of Radiology (Pediatric Radiology)
Current Research and Scholarly InterestsUltrasonic beamforming, imaging methods, systems, and devices.
-
Katharine Dahl
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioDr. Kate Dahl specializes in working with children and families who are affected by medical illness. She has practiced at Stanford since 2014 and is the primary pediatric psychologist for the dialysis, kidney transplant, and liver transplant medical teams. Her work often focuses on adjustment to new diagnosis, coping with illness and treatment, and adherence to the medical regimen. She is particularly interested in the experience of adolescents with chronic medical conditions and leads groups for teens who have received kidney and liver transplants.
-
Laura Dahl
Senior Lecturer of Music
BioPianist Laura Dahl is an active international performer and educator, appearing in venues including Carnegie Hall, the Berlin Philharmonic, San Francisco’s Davies Symphony Hall and Stern Grove Festival, Bing Concert Hall at Stanford University, the Carmel Bach Festival, and the Henley Festival in Great Britain. A specialist in collaborative performance and chamber music, Dahl is the founder and artistic director of the A. Jess Shenson Recital Series at Stanford University, as well as Music by the Mountain, a chamber music festival in Northern California. Dahl is a member of the music faculty at Stanford University, where she teaches collaborative and solo piano, chamber music, art song interpretation, and diction. She has also taught at the New National Theatre Young Artists Training Program in Tokyo, Japan.
Dahl’s education featured training on both coasts of the US and in Germany. She was the first musician to be named a German Chancellor’s Scholar of the Alexander von Humboldt Foundation. She lived two years in Germany, studying under pianist Phillip Moll, baritone Dietrich Fischer-Dieskau, and pianist and composer Aribert Reimann. Dahl holds degrees from the University of Michigan School of Music and the New England Conservatory of Music, where she was a student of Martin Katz, Eckart Sellheim, and Margo Garrett. A graduate of San Francisco Opera’s Merola Program, Dahl served as Assistant Conductor for Western Opera Theater and was Associate Director of the San Francisco Boys Chorus. She has been a coach at the San Francisco Conservatory of Music, the New England Conservatory of Music and the University of Michigan Opera Theater. She was an invited fellow at the prestigious Tanglewood Music Center for two years, in addition to studies at the Banff Academy of Singing (Canada) and the Music Academy of the West (Santa Barbara). Dahl was born and raised in the western states of Colorado and Montana. -
Erpeng Dai
Instructor, Radiology
BioDr. Erpeng Dai's research interest is focused on advanced neuro MRI technique development and application. Previously, he has developed a series of novel techniques for high-resolution and fast diffusion MRI (dMRI). Currently, he is mainly working on distortion-free dMRI, advanced diffusion encoding, and brain microstructure and connectivity studies.
-
Hongjie Dai
The J.G. Jackson and C.J. Wood Professor of Chemistry, Emeritus
BioProfessor Dai’s research spans chemistry, physics, and materials and biomedical sciences, leading to materials with properties useful in electronics, energy storage and biomedicine. Recent developments include near-infrared-II fluorescence imaging, ultra-sensitive diagnostic assays, a fast-charging aluminum battery and inexpensive electrocatalysts that split water into oxygen and hydrogen fuels.
Born in 1966 in Shaoyang, China, Hongjie Dai began his formal studies in physics at Tsinghua U. (B.S. 1989) and applied sciences at Columbia U. (M.S. 1991). He obtained his Ph.D. from Harvard U and performed postdoctoral research with Dr. Richard Smalley. He joined the Stanford faculty in 1997, and in 2007 was named Jackson–Wood Professor of Chemistry. Among many awards, he has been recognized with the ACS Pure Chemistry Award, APS McGroddy Prize for New Materials, Julius Springer Prize for Applied Physics and Materials Research Society Mid-Career Award. He has been elected to the American Academy of Arts and Sciences, National Academy of Sciences (NAS), National Academy of Medicine (NAM) and Foreign Member of Chinese Academy of Sciences.
The Dai Laboratory has advanced the synthesis and basic understanding of carbon nanomaterials and applications in nanoelectronics, nanomedicine, energy storage and electrocatalysis.
Nanomaterials
The Dai Lab pioneered some of the now-widespread uses of chemical vapor deposition for carbon nanotube (CNT) growth, including vertically aligned nanotubes and patterned growth of single-walled CNTs on wafer substrates, facilitating fundamental studies of their intrinsic properties. The group developed the synthesis of graphene nanoribbons, and of nanocrystals and nanoparticles on CNTs and graphene with controlled degrees of oxidation, producing a class of strongly coupled hybrid materials with advanced properties for electrochemistry, electrocatalysis and photocatalysis. The lab’s synthesis of a novel plasmonic gold film has enhanced near-infrared fluorescence up to 100-fold, enabling ultra-sensitive assays of disease biomarkers.
Nanoscale Physics and Electronics
High quality nanotubes from his group’s synthesis are widely used to investigate the electrical, mechanical, optical, electro-mechanical and thermal properties of quasi-one-dimensional systems. Lab members have studied ballistic electron transport in nanotubes and demonstrated nanotube-based nanosensors, Pd ohmic contacts and ballistic field effect transistors with integrated high-kappa dielectrics.
Nanomedicine and NIR-II Imaging
Advancing biological research with CNTs and nano-graphene, group members have developed π–π stacking non-covalent functionalization chemistry, molecular cellular delivery (drugs, proteins and siRNA), in vivo anti-cancer drug delivery and in vivo photothermal ablation of cancer. Using nanotubes as novel contrast agents, lab collaborations have developed in vitro and in vivo Raman, photoacoustic and fluorescence imaging. Lab members have exploited the physics of reduced light scattering in the near-infrared-II (1000-1700nm) window and pioneered NIR-II fluorescence imaging to increase tissue penetration depth in vivo. Video-rate NIR-II imaging can measure blood flow in single vessels in real time. The lab has developed novel NIR-II fluorescence agents, including CNTs, quantum dots, conjugated polymers and small organic dyes with promise for clinical translation.
Electrocatalysis and Batteries
The Dai group’s nanocarbon–inorganic particle hybrid materials have opened new directions in energy research. Advances include electrocatalysts for oxygen reduction and water splitting catalysts including NiFe layered-double-hydroxide for oxygen evolution. Recently, the group also demonstrated an aluminum ion battery with graphite cathodes and ionic liquid electrolytes, a substantial breakthrough in battery science. -
Xianjin Dai, PhD, DABR
Clinical Assistant Professor, Radiation Oncology - Radiation Physics
Current Research and Scholarly InterestsAI in Medicine
Biomedical Physics
Multimodal Imaging
Medical Device
Biomedical Optics
Photoacoustic/Thermoacoustic Imaging
Optical Imaging (Microscopy, OCT, DOT, FMT)
Ultrasound Imaging -
Yuqin Dai
Director, Metabolomics Knowledge Center
BioDr. Yuqin Dai is the Director of the Metabolomics Knowledge Center at Stanford ChEM-H. In this role, she collaborates with faculty in the development and execution of experiments aimed at measuring small molecule drug candidates, endogenous and exogenous metabolites in a variety of biomedical R&D contexts. In addition, she provides strategic vision, mentorship, and leadership in the development of new LC/MS analytical methodologies for metabolomics research, the Metabolomics Knowledge Center’s daily operation and growth.
Dr. Dai came to ChEM-H with 20 years of research, marketing and managerial experiences across biotech/pharma and analytical instrument industries. Prior to joining ChEM-H in January of 2020, Dr. Dai worked at Agilent managing strategic collaborations with key opinion leaders in academia and industry for metabolomics researches, driving new application marketing opportunities, and developing differential solutions to support new LC/MS and automation product introductions. Before Agilent, Dr. Dai led bioanalytical R&D teams and managed DMPK projects to support drug discovery and development programs at three biotech/pharm companies. She was also extensively involved in new technology assessment and implementation. Dr. Dai received her Ph.D. in analytical chemistry from the University of Alberta, Canada, where her research focused on the LC/MS and MALDI/MS instrumentation and method development for proteomics and small molecule applications. -
Gretchen C. Daily
Bing Professor of Environmental Science and Senior Fellow at the Woods Institute for the Environment and, by courtesy, at the Freeman Spogli Institute for International Studies
Current Research and Scholarly InterestsLand use, biodiversity dynamics, ecosystem services
-
Sudeb C. Dalai
Adjunct Clinical Assistant Professor, Medicine - Infectious Diseases
BioDr. Sudeb Dalai, MD PhD is an Infectious Disease Physician at Stanford University School of Medicine and the Palo Alto Medical Foundation. Currently a Clinical Assistant Professor (Teaching) at Stanford, he has taught courses and conducted research in academia/industry for over 18 years.
Dr. Dalai completed his undergraduate degree at MIT, MD and MS at Stanford, PhD in Epidemiology at UC Berkeley School of Public Health, Internal Medicine Residency at UCSD, and Fellowship in Infectious Diseases at Stanford. He has received numerous teaching and leadership awards and research grants and has co-authored multiple peer-reviewed publications. His work has been supported by the Infectious Diseases Society of America, the Howard Hughes Medical Institute, the Paul and Daisy Soros Foundation, and the National Institutes of Health. Dr. Dalai is an internationally-invited speaker and has been featured in multiple media outlets including ABC, NBC, Good Morning America, US News & World Report, Buzzfeed, and The Huffington Post. In 2003 he was elected to the MIT Board of Trustees and in 2020 he was voted as a Board Member of the MIT Club of Northern California. -
Heike Daldrup-Link
Professor of Radiology (General Radiology) and, by courtesy, of Pediatrics (Hematology/Oncology)
Current Research and Scholarly InterestsAs a physician-scientist involved in the care of pediatric patients and developing novel pediatric molecular imaging technologies, my goal is to link the fields of nanotechnology and medical imaging towards more efficient diagnoses and image-guided therapies. Our research team develops novel imaging techniques for improved cancer diagnosis, for image-guided-drug delivery and for in vivo monitoring of cell therapies in children and young adults.
-
Ronald L. Dalman MD
Dr. Walter C. Chidester Professor
Current Research and Scholarly InterestsVascular biology, arterial remodeling, aneurysm development; innovative treatment strategies for AAA, animal models of arterial disease, arterial remodeling and flow changes in spinal cord injury, genetic regulation of arterial aneurysm formation
-
Mihaela Damian MD
Clinical Associate Professor, Pediatrics - Critical Care
Current Research and Scholarly InterestsClinical Pharmacology
Sedation
Solid Organ Transplantation -
William Damon
Professor of Education and Senior Fellow, by courtesy, at the Hoover Institution
Current Research and Scholarly InterestsDevelopment of purpose through the lifespan; educational methods for promoting purpose and the capacity for good work.
-
Edward J. Damrose, MD, FACS
Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Anesthesiology, Perioperative & Pain Medicine
Current Research and Scholarly InterestsAdvanced MRI imaging for laryngeal cancer and swallowing disorders; applications of robotics in microlaryngeal surgery; high speed digital imaging of vocal fold vibration; the effects of hormones and anabolic steroids on vocal function.
-
Francesco Nandkumar Dandekar
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Dandekar is the Associate Director of Sports Psychiatry and a Clinical Assistant Professor at Stanford University. After graduating summa cum laude from the University of Southern California with a B.S. in Biomedical Engineering, he earned a Regents Scholarship to complete his M.D. at UC San Diego, where he received the American Academy of Neurology’s Prize for Excellence. During his residency and fellowship at Stanford, Dr. Dandekar provided care to a variety of patients utilizing a combination of medication management, psychotherapy, and lifestyle changes (sleep, nutrition, exercise, recovery). Teamed with Clinical Professor Dr. Douglas Noordsy, he helped to incorporate psychiatric services into Stanford's sports psychology program, and continues to see elite athletes as part of the Stanford Sports Psychiatry Clinic. He also specializes in treating physicians, and sees many residents, fellows, and attendings in his private practice. In his free time, he enjoys playing tennis, chess, and guitar.
-
Roxana Daneshjou, MD, PhD
Assistant Professor of Biomedical Data Science and of Dermatology
BioDr. Daneshjou studied Bioengineering at Rice University before matriculating to Stanford School of Medicine where she completed her MD and a PhD in Genetics with Dr. Russ Altman as part of the medical scientist training program. She completed dermatology residency at Stanford as part of the research track and completed a postdoc in Biomedical Data Science with Dr. James Zou. She currently is the assistant director of the Center of Excellence for Precision Heath & Pharmacogenomics, director of informatics for the Stanford Skin Innovation and Interventional Research Group (SIIRG), a founding member of the Translational AI in Dermatology (TRAIND) group, and a faculty affiliate of Human-centered Artificial Intelligence (HAI) and the AI in Medicine and Imaging (AIMI) centers.
-
Brian Dang
Clinical Scholar, Radiology
Fellow in RadiologyBioBrian Dang grew up in Rosemead, California. He attended college at the University of California, Irvine, where he majored in Biological Sciences. Brian received his MD degree from Saint Louis University School of Medicine.
-
Linh T Dang
Adjunct Clinical Instructor, Educational Programs and Services (EPS)
BioDr. Linh Dang enjoys practicing full-spectrum primary care. She has a special interest in pediatric and women's health with a particular focus on preventative care.
As a Bay Area native growing up in East San Jose, Dr. Dang especially enjoys working with a diverse population and the most vulnerable and underserved of the community. -
Bruce Daniel
Professor of Radiology (Body Imaging) and, by courtesy, of Bioengineering
Current Research and Scholarly Interests1. MRI of Breast Cancer, particularly new techniques. Currently being explored are techniques including ultra high spatial resolution MRI and contrast-agent-free detection of breast tumors.
2. MRI-guided interventions, especially MRI-compatible remote manipulation and haptics
3. Medical Mixed Reality. Currently being explored are methods of fusing patients and their images to potentially improve breast conserving surgery, and other conditions. -
Kay Daniels
Clinical Professor, Obstetrics & Gynecology - Maternal Fetal Medicine
Current Research and Scholarly InterestsSpecial interest in :
1.Ob simulation as a teaching and training tool
2. Disaster planning for OB units
3. Global women's health -
Kyle Gabriel Daniels
Assistant Professor of Genetics
BioKyle obtained his BS in Biochemistry from the University of Maryland College Park in 2010, conducting undergraduate research with Dr. Dorothy Beckett, PhD. He obtained his PhD in Biochemistry with a certificate in Structural Biology and Biophysics. His dissertation is titled "Kinetics of Coupled Binding and Conformational Change in Proteins and RNA" and was completed in the laboratory of Dr. Terrence G. Oas, PhD. Kyle performed postdoctoral training with Dr. Wendell A. Lim, PhD at UCSF studying how CAR T cell phenotype is encoded by modular signaling motifs within chimeric antigen receptors.
Kyle's lab is interested in harnessing the principles of modularity to engineer receptors and gene circuits to control cell functions.
The lab will use synthetic biology, medium- and high-throughput screens, and machine learning to: (1) Engineer immune cells to achieve robust and durable responses against various cancer targets, (2) Coordinate behavior of multiple engineered cell types in cancer, autoimmune disease, and payload delivery, (3) Control survival, proliferation, and differentiation of hematopoietic stem cells (HSCs) and immune cells, and (4) Explore principles of modularity related to engineering receptors and gene circuits in mammalian cells. -
David Danielson
Adjunct Professor
BioDavid T. Danielson became a Precourt energy scholar at Stanford in 2016. With Stuart Macmillan and Joel Moxley, Dave co-teaches the yearlong course "Energy Transformation Collaborative." This project-based course provides a launchpad for the creation and development of transformational energy ventures. Interdisciplinary student teams research, analyze and refine detailed plans for high-impact opportunities in the context of the new energy venture development framework offered in this course.
Since January 2017, Dave has been managing director of Breakthrough Energy Ventures, a $1 billion fund focused on fighting climate change by investing in clean energy innovation.
From 2012 to 2016, Dave was assistant secretary of the U.S. Department of Energy’s Office of Energy Efficiency & Renewable Energy. There, he directed the U.S. government’s innovation strategy in the areas of sustainable transportation, renewable power, energy efficiency and clean-energy manufacturing, investing about $2 billion annually into American clean-energy innovation. He is considered a global expert in the development of next generation clean-energy technologies and the creation of new R&D and organizational models for high-impact clean energy innovation.
Prior to being appointed by President Obama as assistant secretary, Dave was the first hire at DOE’s Advanced Research Projects Agency– Energy (ARPA-E), a funding agency that focuses on the development of high-risk, high-reward clean-energy technologies. Prior to his government service, he was a clean-energy venture capitalist and, as a PhD student at MIT, was the founder and president of the MIT Energy Club. -
Bernard Dannenberg
Clinical Professor, Pediatrics
Current Research and Scholarly InterestsPediatric Pain Management and Sedation
-
Corinna Darian-Smith, PhD
Professor of Comparative Medicine
On Leave from 06/01/2024 To 01/31/2025Current Research and Scholarly InterestsMy lab looks at the organization and function of central neural pathways that underlie directed manual behavior. We are specifically interested in how these pathways adapt following injury, and use a combination of approaches in monkeys to identify mechanisms mediating neural reorganization and behavioral recovery.
-
Linda Darling-Hammond
Charles E. Ducommun Professor in the School of Education, Emerita
BioLinda Darling-Hammond is the Charles E. Ducommun Professor of Education Emeritus at Stanford University and founding president of the Learning Policy Institute, created to provide high-quality research for policies that enable equitable and empowering education for each and every child. At Stanford she founded the Stanford Center for Opportunity Policy in Education and served as faculty sponsor for the Stanford Teacher Education Program, which she helped to redesign.
Darling-Hammond is past president of the American Educational Research Association and recipient of its awards for Distinguished Contributions to Research, Lifetime Achievement, Research Review, and Research-to-Policy. She is also a member of the American Association of Arts and Sciences and of the National Academy of Education. From 1994–2001, she was executive director of the National Commission on Teaching and America’s Future, whose 1996 report What Matters Most: Teaching for America’s Future was named one of the most influential reports affecting U.S. education in that decade. In 2006, Darling-Hammond was named one of the nation’s ten most influential people affecting educational policy. In 2008, she directed President Barack Obama's Education Policy Transition Team. She is currently President of the California State Board of Education.
Darling-Hammond began her career as a public school teacher and co-founded both a preschool and a public high school. She served as Director of the RAND Corporation’s education program and as an endowed professor at Columbia University, Teachers College before coming to Stanford. She has consulted widely with federal, state and local officials and educators on strategies for improving education policies and practices and is the recipient of 14 honorary degrees in the U.S. and internationally. Among her more than 600 publications are a number of award-winning books, including The Right to Learn, Teaching as the Learning Profession, Preparing Teachers for a Changing World and The Flat World and Education: How America's Commitment will Determine our Future. She received an Ed.D. from Temple University (with highest distinction) and a B.A. from Yale University (magna cum laude). -
Sean Darling-Hammond
Lecturer
BioI am an Assistant Professor at UCLA in the departments of Community Health Sciences, Biostatistics, and Education Policy; a lecturer at Stanford's Graduate School of Education; and the Founder and Principal of BITJustice (Bend It To Justice) LLC.
Approach:
I seek to expand belonging and well-being by conducting research in two domains:
1) identifying k-12 practices that reduce racial disparities in health, discipline, and academic performance
2) identifying social policies that combat and sideline racial bias.
I aim to eschew departmental and methodological silos by conducting research that bridges the fields of public health, education, psychology, law, and public policy. While I have conducted dozens of qualitative research projects and produced work in the critical race theory tradition, my research mainly employs quantitative and econometric methods to analyze large-scale data, understand drivers of population health, and elevate effective public policies (e.g., school-based restorative practices).
Recent scholarship:
A recent article in the Proceedings of the National Academy of Sciences elucidates a new mental health risk for Black students—that schools rapidly grow more punitive towards Black students in the first weeks of the school year. It also shows how early-year data can be used to detect—and target interventions towards—schools where racial disparities in discipline are likely to emerge. Another project (published by the Learning Policy Institute and under review at AERA Open) reviews millions of California public student records and finds evidence that student exposure to restorative practices may reduce exclusionary discipline, improve academic achievement, and reduce related racial disparities; and that school adoption may reduce school-wide victimization, misbehavior, gang membership, depression, and sleep deprivation, and may increase school climate and student GPA. Two related projects find that—for Black boys and Black girls—exposure to restorative practices is related to lower depressive symptom, suicidal ideation, and substance abuse rates. A final project using this data finds that Black male and female students who perceive their School Resource Officers as exhibiting racial bias have higher rates of depressive symptoms, anxiety, and psychological distress. I also conduct randomized controlled trials to evaluate means of combatting racial bias. A recent paper in Science Advances reports on a teacher-facing growth-mindset intervention that reduced racial disparities in teachers’ responses to student misbehavior. And a recent field experiment conducted in partnership with the City of Denver found that a scalable racial bias training enhanced public employees’ abilities to combat racial bias in the workplace and society.
Scholarly Impact:
My work has been published in Science Advances, Proceedings of the National Academy of Sciences, and Nature Human Behavior; cited in over 700 peer reviewed articles; and referenced by the New York Times, the Washington Post, NBC, the Department of Education Regional Education Labs, and the House Judiciary Committee.
Teaching:
I have received strong student evaluations in four courses at UCLA (two in health program planning and evaluation, one in approaches to interdisciplinary scholarship, and one to empower students from underrepresented backgrounds to succeed in our comprehensive exam). While earning my PhD at UC Berkeley, I also served as an instructor for multiple statistics classes and received UC Berkeley’s “Outstanding Graduate Student Instructor Award.” Guided by cutting-edge psychological theory, I developed and piloted a package of practices and teaching materials which led multiple cohorts of under-represented minority students to realize minimum raw scores of 90% in statistics classes, and (according to anonymous, in-depth, post-surveys) to overcome many negative internalized beliefs and adopt a growth mindset. -
Gary Darmstadt
Professor (Teaching) of Pediatrics (Neonatology) and, by courtesy, of Obstetrics and Gynecology
Current Research and Scholarly InterestsI have extensive experience in the development of global health innovations and in working to test and scale-up health interventions. At Stanford University, I am playing a leading role in developing global women and children’s health research and educational programs, including the establishment of a Global Center for Gender Equality at Stanford University. My research focuses on advancing child health and development in low resource settings and advancing gender equality and health globally, and includes several applications of artificial intelligence. Before joining Stanford, I was Senior Fellow at the Bill & Melinda Gates Foundation (BMGF), where I led the development of initiatives to address gender inequalities and empower women and girls. Prior to this role, I served as the BMGF Director of Family Health, leading strategy development and implementation across maternal, newborn and child health, nutrition, and family planning. In this role, I was responsible for investments ranging from scientific discovery to intervention development and delivery of interventions at scale. I worked closely with the Discovery team to shape discovery and development investments and was a co-founder of the Saving Lives at Birth Development Grand Challenge, the Putting Women and Girls at the Center of Development Grand Challenge, and the Healthy Birth, Growth and Development initiative. Based on these experiences, I understand how to identify knowledge gaps and generate evidence of impact for new interventions, and how to utilize evidence to influence the policy dialogue leading to programmatic adoption and scale-up of interventions in low income settings. As Director of Family Health, I also co-led the development and implementation of the BMGF global health strategy for India, which cuts across multiple health and development sectors. Before joining BMGF, I was Associate Professor and Founding Director of the International Center for Advancing Neonatal Health in the Department of International Health at the Johns Hopkins Bloomberg School of Public Health. I led the development of newborn health research, including numerous facility- and community-based maternal and child health research trials. Before joining Johns Hopkins, I was Senior Research Advisor for the $50M Saving Newborn Lives program of Save the Children-US, where I led the development and implementation of the global research strategy for newborn health and survival.
